Weekly Newsletter   Challenge account   Weekly Newsletter   

Posted by Martin July 28, 2018


ABBV reported earnings and beat estimates, however, the sales of Humira disappointed, according to Wall Street. It is not easy to satisfy Wall Street young analysts, many of them so young that they even haven’t experienced 2008 recession, some old that they see doom and gloom at every corner. All they do is that they Continue reading →

Posted by Martin January 08, 2013

Unloading ABBV from my portfolio, what about Abbott?

I was looking for information about ABBV and ABT to find out whether to keep these stocks or get rid of them. It was very difficult to find anything which would help me to make the decision. Keep the stocks or not? That’s the question. Mostly I used information about ABBV and ABT from Morningstar Continue reading →